Dr. Reddy's Gets CDSCO Panel Nod To Study Tegoprazan for gastrointestinal diseases Dr. Divya Colin4 July 2023 6:00 PM ISTNew Delhi: The drug major Dr. Reddy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Need well-designed protocol with statistically validated sample size: CDSCO Panel Tells Dr. Reddy's on Nerivio Dr. Divya Colin4 Jun 2023 6:00 PM ISTNew Delhi: In line with the proposal to conduct a pivotal clinical investigation of the proposed product Nerivio, the Subject Expert Committee (SEC)...
Dr Reddy's Gets CDSCO Panel Nod to Market Sumatriptan Nasal Spray to treat acute migraine attacks Dr. Divya Colin27 May 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization(CDSCO) has granted approval to drug major...
Trademark dispute over anti-ulcer drug Omez: Delhi HC rules in favour of Dr Reddy's Shubhangi Gandhi5 Oct 2021 7:09 PM ISTNew Delhi: In a relief to Dr Reddy's Laboratories, Delhi High Court has accepted an affidavit filed by West-Coast Pharmaceutical Works agreeing...
Dr Reddys launches Icosapent Ethyl Capsules in US Ruchika Sharma22 Jun 2021 2:24 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd., along with its subsidiaries together today announced the launch of Icosapent Ethyl Capsules, 1 gram ...
Dr Reddy's Labs launches authorized generic version of NitroDur® (nitroglycerin) Transdermal Infusion System in US Ruchika Sharma16 April 2020 11:09 AM ISTHyderabad and Princeton: Dr Reddy's Laboratories Ltd. has announced the launch of an authorized generic version of NitroDur® (nitroglycerin)...
Dr Reddy's Labs launches Amphetamine Sulfate Tablets USP in US Market Medical Dialogues Bureau15 April 2020 3:47 PM ISTHyderabad and Princeton: Dr Reddy's Laboratories Ltd. has announced the launch of Amphetamine Sulfate Tablets USP, a therapeutic equivalent generic...
Dr Reddy's Labs launches Invista(dasatinib) in India Medical Dialogues Bureau15 April 2020 12:30 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd., has announced the launch of Invista®, a formulation of Dasatinib that is bioequivalent to the innovator...
